Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Proteomics International pivots to sales with management shake-up

David Morris takes helm to advance Promarker diagnostics commercialization, following US lab accreditation from the College of American Pathologists and regulatory approvals.

Summary by Sydney Morning Herald
Proteomics International Laboratories has named medtech veteran David Morris as CEO and managing director to drive the commercial rollout of its Promarker diagnostics.

3 Articles

Sydney Morning HeraldSydney Morning Herald
+2 Reposted by 2 other sources
Lean Left

Proteomics International pivots to sales with management shake-up

Proteomics International Laboratories has named medtech veteran David Morris as CEO and managing director to drive the commercial rollout of its Promarker diagnostics.

·Sydney, Australia
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Sydney Morning Herald broke the news in Sydney, Australia on Wednesday, January 14, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Australia icon

Australia

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal